Skip to main content

MoneyWorks4Me

Bacil Pharma - Quaterly Results

12 Aug 2025 Evaluate
The revenue for the June 2025 quarter is pegged at Rs. 0.00 millions against Rs. 0.00 millions recorded during the year-ago period.The Total Profit for the quarter ended June 2025 of Rs. 6.68 millions grew from Rs.-0.33 millions Operating profit Margin for the quarter ended June 2025 improved to 8.93% as compared to -0.33% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 10.02 0.11 9009.09 10.02 0.11 9009.09 6.61 1.31 404.58
PBIDT 8.93 -0.33 -2806.06 8.93 -0.33 -2806.06 4.08 -0.57 -815.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 8.93 -0.33 -2806.06 8.93 -0.33 -2806.06 4.08 -0.57 -815.79
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 -50.00
PBT 8.93 -0.33 -2806.06 8.93 -0.33 -2806.06 4.07 -0.59 -789.83
TAX 2.25 0.00 0.00 2.25 0.00 0.00 0.03 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00
PAT 6.68 -0.33 -2124.24 6.68 -0.33 -2124.24 4.04 -0.59 -784.75
Equity 139.70 58.90 137.18 139.70 58.90 137.18 139.70 58.90 137.18
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1886.05
Dr. Reddys Labs. 1381.10
Cipla 1409.30
Lupin 2018.90
Zydus Lifesciences 1204.00
View more..